Successful treatment of recalcitrant follicular lichen planus (lichen planopilaris) with the topical JAK 1/2 inhibitor ruxolitinib-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Successful treatment of recalcitrant follicular lichen planus (lichen planopilaris) with the topical JAK 1/2 inhibitor ruxolitinib

Published:2024-08-14 Issue: Volume: Page:
ISSN:2768-6566
Container-title:JEADV Clinical Practice
language:en
Short-container-title:JEADV Clinical Practice

Author:

Fetter Tanja¹,Wilsmann‐Theis Dagmar¹^ORCID,de Vos‐Hillebrand Luka¹,Novak Natalija¹,Wenzel Joerg¹^ORCID

Affiliation:

1. Department of Dermatology and Allergy, Center for Skin Diseases University Hospital Bonn Bonn Germany

Abstract

AbstractWe report the successful treatment of a patient with refractory follicular lichen planus (LP) with topical ruxolitinib, a Janus kinase (JAK) 1/2 inhibitor, which resulted in significant improvement of lesional skin within 1 month of daily use.

Publisher

Wiley

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jvc2.515

Reference13 articles.

1. Lichen planopilaris: retrospective study on the characteristics and treatment of 291 patients

2. JAK inhibitors in lichen planus: a review of pathogenesis and treatments

3. A Practical Approach to the Diagnosis and Management of Classic Lichen Planopilaris

4. Lichen Planus Activity and Damage Index (LiPADI)–Creation of the Questionnaire

5. Does mitochondrial dysfunction of hair follicle epithelial stem cells play a role in the pathobiology of lichen planopilaris?

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP